Could the largest market for the new schizophrenia drug xanomeline and trospium chloride (Cobenfy) be in Alzheimer's disease ...

Researchers uncover promising evidence that xenon gas, commonly used in anesthesia, may help reduce brain deterioration and ...

As an Alzheimer’s Congressional Team Advocate, I want all Pennsylvanians to know the staggering statistics regarding Alzheimer’s and other dementia for residents of the state. As of 2020, there were ...

Late-onset Alzheimer's disease is a debilitating, progressive neurodegenerative disease that affects about 7 million ...

Aerobic exercise significantly lowers Alzheimer’s disease markers and improves brain health, offering a promising preventive ...

People who care for patients with Alzheimer's or other dementia must be alert when winter weather turns dangerous, advises ...

Vigil Neuroscience reported a strong safety profile and 50% sTREM2 reduction in an early-stage trial for VG-3927, potentially representing a new avenue for treating Alzheimer’s disease.

Recommendations are presented for the diagnostic evaluation of patients with Alzheimer disease (AD) or AD and related dementias (ADRD).

A program in Portsmouth aims to help families who have a loved one with Alzheimer’s and other related conditions that could ...

Vigil Neuroscience has reported early clinical data on its Alzheimer’s disease candidate, positioning the biotech to advance its small molecule in the footsteps of AbbVie and Alector’s failed rival ...

Xenon gas, currently used in medicine as an anesthetic and neuroprotective agent for treating brain injuries, showed potential in protecting the brain in studies.

Frigid temperatures and unprecedented snowfall in various parts of the U.S. can pave the way for heightened dangers this ...